Laura Grant
HEALTHCARE SERVICES GROUPAbout Laura Grant
Laura Grant, age 45, has served as an independent director of Healthcare Services Group (HCSG) since 2020. She is Managing Partner and President of Chatham Financial (since 2022) and previously served as COO, Managing Director in Global Real Estate, and co‑head of Chatham’s European business (2017–2022), with a background in risk management for REITs focused on interest rate and FX hedging; earlier in her career she worked in Booz Allen Hamilton’s Capital Asset Management group . She is designated independent under Nasdaq rules and serves on HCSG’s Audit Committee (not chair) . During 2024, the Board held four meetings and each member attended at least 75% of aggregate Board and committee meetings; the Audit Committee met five times .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Chatham Financial | Managing Partner & President | 2022–present | Oversees firm; board member of Chatham Financial |
| Chatham Financial | COO; Managing Director, Global Real Estate; Co‑head, Europe | 2017–2022 (Europe co‑head) | Focused on REIT risk management (rates/FX) |
| Booz Allen Hamilton | Capital Asset Management | Not disclosed (prior to Chatham) | Consulting on capital asset management |
External Roles
| Organization | Role | Public/Private | Tenure |
|---|---|---|---|
| Chatham Financial | Board Member | Private | Since 2022 |
Board Governance
- Committees: Audit Committee member; Audit met 5 times in 2024; committee independence per Nasdaq/Rule 10A‑3 affirmed (Audit chair and financial expert is Kurt Simmons, Jr.) .
- Independence: Listed as independent; majority of Board independent (Casey, Castagnino, Grant, McFadden, Ottaviano, Simmons, Visconto, Whalen) .
- Attendance: Board met 4 times in 2024; each director attended ≥75% of Board and assigned committee meetings .
- Skills/Expertise: Operational, Executive, Financial, Real Estate (per Board Skills Matrix) .
- Leadership: Not a committee chair; Board chaired by independent director Jude Visconto .
Fixed Compensation (Director)
| Metric (FY2024) | Amount |
|---|---|
| Fees earned/paid in cash | $0 (elected DSUs) |
| Applicable quarterly retainer if taken in cash (Audit Committee member) | $7,500 per quarter ($30,000 annual equivalent) |
| Total director compensation | $70,015 |
Notes: Directors may elect to receive retainers in fully vested DSUs equal in value to the cash retainer; Ms. Grant elected DSUs for 2024 .
Performance Compensation (Director Equity)
| Award Type | Grant/Status | Amount/Terms |
|---|---|---|
| Deferred Stock Units (DSUs) | 2024 DSU awards (grant date fair value) | $70,015; DSUs vest in 1 year; payable at earliest of 5‑year anniversary, death/disability/separation from Board, or change of control |
| Stock Options (legacy) | Vested options outstanding (12/31/2024) | 4,001 options exercisable (director footnote) |
Policy highlights: Directors can elect DSUs in lieu of cash retainers; DSU payments may be deferred to separation; change‑of‑control is an acceleration trigger under the 2020 Plan .
Other Directorships & Interlocks
- Other public company boards: None disclosed in HCSG’s proxy for Ms. Grant .
- Internal interlocks: Ms. Grant is not on HCSG’s Nominating, Compensation & Stock Option (NCSO) Committee; the proxy reports no compensation committee interlocks during 2024 .
Expertise & Qualifications
- Risk management for REITs (interest rate and FX hedging); Real Estate finance; Executive leadership; Operational experience .
- Audit oversight experience as Audit Committee member (independent; committee financial expert designated as Simmons, Jr.) .
Equity Ownership
| Holder | Beneficial Ownership (3/31/2025) | % of Class | Notable Details |
|---|---|---|---|
| Laura Grant | 16,829 shares | <1% | Includes 4,001 currently exercisable non‑qualified stock options |
Company anti‑hedging/blackout policy applies to non‑employee directors; the proxy notes compliance with Section 16(a) filing requirements for 2024 (certain January 2025 late Form 4s related to phantom stock for executives, not directors) .
Governance Assessment
- Alignment: 100% of Ms. Grant’s 2024 director pay was in equity (DSUs) due to her election, signaling alignment with long‑term shareholder interests; DSUs vest in one year with deferred settlement features .
- Independence/Conflicts: Ms. Grant is independent and serves on the Audit Committee; no related‑party transactions involving Ms. Grant were disclosed in the proxy (related‑party disclosures pertain to a management relative and to director Whalen’s affiliated firm engagement) .
- Engagement: Board‑wide attendance threshold (≥75%) was met; Audit Committee met 5 times in 2024, supporting active oversight cadence .
- Pay governance backdrop: Shareholders supported say‑on‑pay at ~91% in 2024, indicating a constructive governance environment, though this pertains to executives rather than directors .
RED FLAGS: None identified specific to Ms. Grant in the proxy. No attendance shortfalls, no related‑party transactions, no hedging/pledging disclosures adverse to policy were noted for her .